- Report
- February 2024
Cyprus
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Colombia
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
China
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Chile
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Canada
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Bulgaria
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Brazil
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Bolivia
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Belgium
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Belarus
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Bangladesh
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Bahrain
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Austria
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Australia
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Argentina
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
Albania
From €2712EUR$2,850USD£2,322GBP
- Report
- February 2024
United States
From €3663EUR$3,850USD£3,136GBP
- Report
- February 2024
United Kingdom
From €3330EUR$3,500USD£2,851GBP
- Report
- February 2024
Spain
From €3330EUR$3,500USD£2,851GBP
- Report
- February 2024
Japan
From €3330EUR$3,500USD£2,851GBP
Immunofixation is a type of in vitro diagnostics (IVD) used to identify and quantify monoclonal immunoglobulins and light chains in serum and urine. It is a two-step process that involves the use of antibodies to separate and identify the components of a sample. The first step involves the use of a polyclonal antibody to separate the sample into its component parts. The second step involves the use of a monoclonal antibody to identify the components of the sample. Immunofixation is used to diagnose and monitor a variety of conditions, including multiple myeloma, Waldenström's macroglobulinemia, and amyloidosis.
The Immunofixation market is a rapidly growing segment of the IVD industry. It is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for accurate and timely diagnosis. Companies in the Immunofixation market include Abbott, Bio-Rad Laboratories, Siemens Healthineers, Ortho Clinical Diagnostics, and Thermo Fisher Scientific. Show Less Read more